Unraveling the role of miRNAs in the diagnosis, progression, and drug resistance of oral cancer-Reference-Cited by-同舟云学术

Unraveling the role of miRNAs in the diagnosis, progression, and drug resistance of oral cancer

Published:2024-01 Issue: Volume:253 Page:155027
ISSN:0344-0338
Container-title:Pathology - Research and Practice
language:en
Short-container-title:Pathology - Research and Practice

Author:

Doghish Ahmed S.,Elshaer Shereen Saeid,Fathi Doaa,Rizk Nehal I.,Elrebehy Mahmoud A.,AL-Noshokaty Tohada M.,Elballal Mohammed S.,Abdelmaksoud Nourhan M.,Abdel-Reheim Mustafa Ahmed,Abdel Mageed Sherif S.,Zaki Mohamed Bakr,Mohammed Osama A.,Tabaa Manar Mohammed El,Elballal Ahmed S.,Saber Sameh,El-Husseiny Hussein M.,Abulsoud Ahmed I.

Funder

University of Bisha

Shaqra University

Publisher

Elsevier BV

Subject

Cell Biology,Pathology and Forensic Medicine

Reference368 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA: a Cancer J. Clin.,2021

2. Noncoding RNAs in oral cancer;Balakittnen;WIREs RNA,2023

3. Histological and molecular aspects of oral squamous cell carcinoma (Review);Rivera;Oncol. Lett.,2014

4. Circulating miRNA as a biomarker in oral cancer liquid biopsy;Roi;Biomedicines,2023

5. Overview of evidence-based chemotherapy for oral cancer: focus on drug resistance related to the epithelial-mesenchymal transition;Sha;Biomolecules,2021

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging Trends in Novel Drug Delivery Systems for the Effective Treatment of Oral Cancer;Current Cancer Therapy Reviews;2024-06-05

2. LncRNA HOXA‑AS2 is a prognostic and clinicopathological predictor in patients with cancer: A meta‑analysis;Oncology Letters;2024-03-22